David B. Fischer net worth and biography

David Fischer Biography and Net Worth

Director of Balchem

David B. (Dave) Fischer serves as Independent Director of the Company. Mr. Fischer served as Chief Executive Officer and a director of Greif, Inc. from November 1, 2011, to October 31, 2015, and as President of Greif, Inc. from October 2007 to October 31, 2015. Greif, Inc. is a manufacturer and provider of industrial packaging and services including steel, fiber, flexible, corrugated, intermediate bulk, reconditioned and multiwall containers and containerboard, and filling, packaging, industrial packaging reconditioning and land management consulting services for a wide range of industries. From 2007 to October 2011, Mr. Fischer also served as Chief Operating Officer of Greif, Inc. From 2004 to 2007, Mr. Fischer served as Senior Vice President and Divisional President, Industrial Packaging & Services-Americas, which also included responsibility for Africa. He assumed additional responsibility for Australia and Asia in 2005 and 2006, respectively. Mr. Fischer serves as a director of Balchem Corporation, a manufacturer of performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries, and DoMedia Inc., a privately held technology company that operates a market for out-of-home advertising sales. Mr. Fischer is also chairman of the board and co-founder of 10x Engineered Materials LLC, a privately held materials science based company which manufactures high tech industrial abrasives. He is also a past director of two not-for-profit entities: Habitat for Humanity International and The Ohio State University Wexner Medical Center. Mr. Fischer holds a Bachelor’s degree in chemistry from Purdue University.

What is David B. Fischer's net worth?: The estimated net worth of David B. Fischer is at least $1.88 million as of September 11th, 2023. Mr. Fischer owns 13,469 shares of Balchem stock worth more than $1,875,693 as of April 27th. This net worth approximation does not reflect any other assets that Mr. Fischer may own. Learn More about David B. Fischer's net worth.
How do I contact David B. Fischer?: The corporate mailing address for Mr. Fischer and other Balchem executives is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. Balchem can also be reached via phone at (845) 326-5600 and via email at [email protected]. Learn More on David B. Fischer's contact information.
Has David B. Fischer been buying or selling shares of Balchem?: David B. Fischer has not been actively trading shares of Balchem during the last ninety days. Most recently, David B. Fischer sold 3,800 shares of the business's stock in a transaction on Monday, September 11th. The shares were sold at an average price of $131.57, for a transaction totalling $499,966.00. Following the completion of the sale, the director now directly owns 13,469 shares of the company's stock, valued at $1,772,116.33. Learn More on David B. Fischer's trading history.
Who are Balchem's active insiders?: Balchem's insider roster includes William Backus (CAO), David Fischer (Director), Scott Mason (VP), and Job van Gunsteren (VP). Learn More on Balchem's active insiders.
Are insiders buying or selling shares of Balchem?: During the last twelve months, insiders at the basic materials company sold shares 7 times. They sold a total of 82,730 shares worth more than $12,643,043.10. The most recent insider tranaction occured on February, 26th when CAO William A Backus sold 7,000 shares worth more than $1,086,330.00. Insiders at Balchem own 1.8% of the company. Learn More about insider trades at Balchem.
Information on this page was last updated on 2/26/2024.

David B. Fischer Insider Trading History at Balchem

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/11/2023	Sell	3,800	$131.57	$499,966.00	13,469
3/20/2023	Sell	3,000	$127.01	$381,030.00	17,269

David B. Fischer Buying and Selling Activity at Balchem

Balchem Company Overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Today's Range

Now: $139.26

$138.52

$139.92

50 Day Range

MA: $152.05

$138.50

$157.27

2 Week Range

Now: $139.26

$110.74

$159.52

Volume

58,508 shs

Average Volume

80,290 shs

Market Capitalization

$4.49 billion

P/E Ratio

41.57

Dividend Yield

0.57%

Beta

0.71

Why Big Pharma is Investing Billions in This Biotech

From Behind the Markets | Ad

If you're on the hunt for a great biotech stock under $20... you need to see this video.

Watch my exclusive report here>>>